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To enable rapid and reliable detection of poxviruses in
clinical and environmental specimens, a diagnostic
approach was developed to detect <3 PFU of infectious
poxvirus particles in <5 hours. This approach involved virus
culture combined with real-time reverse transcription–poly-
merase chain reaction detection of 2 viral genes expressed
immediately after infection.
A
fter the attacks with anthrax spores in the fall of 2001
in the United States, the potential abuse of variola
virus or genetically engineered orthopoxviruses in bioter-
rorist plots has been intensely discussed (1–3). To date,
several diagnostic assays have been developed to rapidly
and reliably detect poxvirus particles or poxvirus genomes
in suspected samples. Electron microscopy (EM) can also
identify poxvirus particles (4,5). However, it cannot differ-
entiate between orthopoxvirus species and has limited sen-
sitivity because reliable detection is only possible with
particle concentrations >106/mL (6).
Molecular methods such as real-time polymerase chain
reaction (PCR) are more sensitive, detecting <10 genome
equivalents per PCR, but PCR can only identify short
stretches of poxvirus DNA (1,7). Nevertheless, since EM
and PCR cannot discriminate between infectious and non-
infectious virus particles or nucleic acids, they are not sat-
isfactory when an evaluation of the infectious capacity of
viral particles is required.
Identifying viral particles by EM is usually sufficient to
diagnose a poxvirus infection in clinical samples from
patients with typical symptoms of this infection. Virus
concentration should exceed 106 particles/mL; however,
even at these concentrations only the virus family can be
determined, and no additional classification is possible.
Detection of poxvirus nucleic acids is sensitive and per-
mits identification of virus-specific sequences and differ-
entiation of a variola virus infection from an infection with
other orthopoxviruses. Thus, a combination of both meth-
ods is recommended for frontline diagnostic procedures,
and a positive result obtained by 1 of these methods would
initiate a confirmation diagnosis.
If symptoms in clinical cases are unambiguous, they
can usually be attributed to a replication-competent infec-
tious virus. In contrast, in environmental samples, includ-
ing samples from suspected parcels, a positive EM or PCR
result would also require virus isolation to prove that par-
ticles could replicate to make a reasonable risk assessment
(German Smallpox Preparedness Plan, available from
www.rki.de).
With environmental samples, the unknown factor is to
what extent the sample matrix influences the ability of the
virus to replicate, and detecting particles by EM or DNA
by PCR does not necessarily indicate infectious particles.
The only diagnostic approach to identify replication-com-
petent poxvirus particles is their propagation in a suitable
cell culture system. With this system, it takes >1 day to
reliably detect poxvirus proteins with specific antibodies.
We combined a cell culture approach that identifies
virus replication with the speed and sensitivity of real-time
PCR. To this end, we changed the target of real-time PCR
from poxvirus DNA to poxvirus mRNA genes that are
highly expressed during the first few hours of the infection
cycle. Expression levels of these genes enable sensitive
detection 1–2 hours after infection. The complete diagnos-
tic approach can be performed in 96-well plates and pro-
vides results within 5 hours of receipt of a sample.
The Study
Briefly, 1.5 × 104 HEpG2 cells were infected with 150
PFU of vaccinia virus strain Lister Elstree. A 15-minute
centrifugation step at 1,000 × g increased the efficacy of
infection by a factor of 10 compared with regular infection
at 37°C (data not shown). Virus-containing supernatant
was removed, and virus was allowed to replicate for 4 h.
Every 30 minutes an aliquot of cells was harvested, and
RNA and DNA were isolated by standard procedures
(RNAeasy kit and Blood DNA kit, Qiagen, Hilden,
Germany). RNA was subjected to 1-step real-time reverse
transcription–polymerase chain reaction (RT-PCR)
(QuantiTect Probe RT-PCR kit, Qiagen) in a real-time PCR
7700/7900/7500 sequence detection system (Applied
Biosystems, Foster City, CA, USA). Amplification of frag-
ments of the F1L gene, an apoptosis modulator, and the
rpo18 gene, the small subunit of viral RNApolymerase (1)
(both genes are encoded by all poxviruses including vario-
la virus), was monitored by gene-specific 5′-nuclease
probes.
Expression of the F1L and rpo18 genes could be detect-
ed 30 minutes and 1 hour after infection, respectively. The
copy number of the transcripts was determined by compar-
ison with in vitro translated RNAmolecules that were gen-
erated according to standard procedures. Briefly, RNAwas
transcribed in vitro by T7 RNA polymerase (RiboMax
RNA production system, Promega, Madison, WI, USA)
from plasmids containing the respective PCR target
region, and plasmid DNA was digested with DNase.
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increased 2.7 × 104-fold, indicating early expression of
viral genes in the cells analyzed. The rpo18 mRNA
showed a 410-fold increase after 4 hours. Quantification of
viral DNA showed a slight decrease in DNA during the
same period, and the ratios of RNAto DNAincreased sub-
stantially, as shown in Figure 1. This high ratio of poxvirus
RNA to poxvirus DNA demonstrates that a possible back-
ground of genomic viral DNA, which is derived from
poxvirus particles that are noninfectious or from traces of
poxvirus genomic DNA in the RNA preparation, does not
result in false-positive results in real-time RT-PCR.
To evaluate the detection limit of our approach, a pro-
bit analysis was performed by repetition of the detection
(N = 12) of vaccinia virus strain Lister Elstree. Vaccinia
virus stocks were titrated according to standard proce-
dures. The virus load used varied from 1.5 × 103 PFU to
0.1 PFU, which is equivalent to a multiplicity of infection
of 0.15 to 1 × 10−5 (8). As shown in Figure 2, after 2 hours
of incubation, real-time PCR analysis showed that the F1L
assay detected 3 PFU of vaccinia virus, and the rpo18
detected 6 PFU of vaccinia virus with a confidence inter-
val of 95%.
Conclusions
The extremely low detection limit of the new assay
indicates that environmental samples, which may contain
cell culture inhibitory substances and are routinely subject-
ed to crude separation steps such as low-speed centrifuga-
tion before analyses, can be diluted by several orders of
magnitude to dilute inhibitors while maintaining the viral
load at detectable levels. The time frame required for the
individual steps of the diagnostic approach is 15 minutes
for sample infection, 2–4 hours for virus propagation, 30
minutes for RNA preparation, and 2 hours for real-time
RT-PCR. Use of alternative, more rapid real-time PCR
platforms further reduces the time required to complete an
assay. For poxvirus-positive results, fluorescence melting
curve analysis of the rpo18 PCR product allows rapid and
reliable differentiation of variola virus (1). Under optimal
conditions, results can be obtained <5 hours after the sam-
ple has arrived in the laboratory.
In summary, the combination of cell culture and real-
time RT-PCR detection of early, highly expressed viral
genes permits detection of minute quantities of infectious
poxvirus particles in a suspected sample. Identification of
variola virus can be performed by fluorescence melting
curve analysis, therefore permitting a reliable risk assess-
ment of a suspect parcel.
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